Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation

Journal of Cystic Fibrosis

Volumn 9, Issue 3, 2010, Pages 199-204

  Sc, Noa Nezer M ^a   Shoseyov, David ^a   Kerem, Eitan ^a   Zangen, David Haim ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cystic fibrosis related diabetes; Normal glucose tolerance; Pulmonary exacerbations

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LUNG FUNCTION; MALE; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; STEADY STATE; BLOOD; COMPLICATION; DISEASE COURSE; GLUCOSE TOLERANCE TEST; YOUNG ADULT;

ADOLESCENT; BLOOD GLUCOSE; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; PILOT PROJECTS; YOUNG ADULT;

EID: 77953364064     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.02.001     Document Type: Article

References (48)

1. Cystic fibrosis foundation patient registry 2006, 2005 Annual Data Report to the Center Directors, Cystic Fibrosis Foundation, Bethesda, MD.
2. Moran A., Doherty L., Wang X., Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1988, 133:10-16.
3. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiøtz P.O., Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994, 83:72-77.
4. Finkelstein S.M., Wielinski C.L., Elliott G.R., et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988, 112:373-377.
5. Koch C., Rainisio M., Madessani U., et al. Investigators of the European epidemiologic registry of cystic fibrosis. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001, 32(5):343-350.
6. Marshall B.C., Butler S.M., Stoddard M., Moran A.M., Liou T.G., Morgan W.J. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005, 146(5):681-687.
7. Annual Data Report 1998, Cystic Fibrosis Foundation Patient Registry, Cystic Fibrosis Foundation, Bethesda, MD.
8. Lanng S., Thorsteinsson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992, 151(9):684-687.
9. Milla C.E., Warwick W.J., Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000, 162:891-895.
10. Lanng S., Hansen A., Thorsteinnson B., Nerup J., Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. Br Med J 1995, 311:655-659.
11. Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005, 4:7-26.
12. Elder D.A., Wooldridge J.L., Dolan L.M., D'Alessio D.A. Glucose tolerance, insulin secretion and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. J Pediatr 2007, 151:653-658.
13. Kopito L.E., Shwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res 1976, 10(8):742-749.
14. Iannucci A., Mukai K., Johnson D., Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1984, 15(3):278-284.
15. Austin A., Kalhan S.C., Orenstein D., Nixon P., Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 1994, 79:80-85.
16. Moran A., Pyzdrowski K., Weinreb M.D. Insulin sensitivity in cystic fibrosis. Diabetes 1994, 43:1020-1026.
17. Hardin D.S., LeBlanc A., Lukenbaugh S., Seilheimer D.K. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997, 130:948-956.
18. Cucinotta D., Conti Nabali S., Arrigo T., et al. Beta cell function, peripheral sensitivity to insulin and islet cell auto-immunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990, 34:33-338.
19. Lanng S., Thorsteinsson B., Roder M.E., Nerup J., Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrino 1994, 41:217-223.
20. Cucinotta D., Luca F., Gigante A., et al. No changes in insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994, 130:253-258.
21. Ahmad T., Nelson R., Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994, 43:163-167.
22. Boom A., Lybaert P., Pollet J.F., et al. Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas. Endocr 2007, 32:197-205.
23. Stalvey M.S., Muller C., Schatz D.A., et al. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury. Diabetes 2006, 55:1939-1945.
24. Yung B., Noormohamed F.H., Kemp M., Hooper J., Lant A.F., Hodson M.E. Cystic fibrosis related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med 2002, 19(3):221-226.
25. Zeller M., Vergs B., L'Huillier I., Brun J.M., Cottin Y. Glycemia in acute coronary syndromes. Diabetes Metab 2006, 32(2):42-47.
26. Faustino E.V., Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005, 146:30-34.
27. Rabin H.R., Butler S.M., Wohl M.E., et al. Epidemiologic study of cystic fibrosis. Pulmonary Exacerbations in Cystic Fibrosis. Pediatr pulmonol 2004, 37(5):400-406.
28. Bingley P.J., Colman P., Eisenbarth G.S., et al. Standardization of IVGTT to predict IDDM. Diabetes Care 1992, 15(10):1313-1316.
29. Moran A., Hardin D., Rodman D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus. A consensus conference report. Diabetes Res Clin Pract 1999, 45(1):61-73.
30. Adler A.I., Shine B.S., Chamnan P., Haworth C.S., Bilton D. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 2008, 31:1789-1794.
31. De Schepper J., Hachimi-Idrissi S., Smitz J., Dab I., Loeb H. First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm Res 1992, 38(5-6):260-263.
32. Cucinotta D., De Luca F., Arrigo T., et al. First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J Pediatr Endocrinol 1994, 7(1):13-17.
33. Tofé S., Moreno J.C., Máiz L., Alonso M., Escobar H., Barrio R. Insulinsecretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 2005, 152:241-247.
34. Marik P.E., Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004, 30(5):748-756.
35. McGuinness O.P. Defective glucose homeostasis during infection. Annu Rev Nutr 2005, 25:9-35.
36. Rafii M., Chapman K., Stewart C., et al. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 2005, 81(2):421-426.
37. Rolon M.A., Benali K., Munck A., et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001, 90:860-867.
38. Arvanitakis S.N., Tsinopoulou A.G., Karamouzis M. Insulin improves clinical status of patients with cystic fibrosis related diabetes mellitus. Acta Paediatr 2001, 90:515-519.
39. Dobson L., Hattersley T., Tiley S., Elworthy S., Oades P.J., Sheldon C.D. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002, 87(5):430-431.
40. Hardin D.S., LeBlance A., Lukenbaug S., Para L., Seilheimer D.K. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1988, 101:433-437.
41. Moran A., Milla C., DuCret R., Nair K.S. Protein metabolism in clinically stable adult CF patients with abnormal glucose tolerance. Diabetes 2001, 50:1336-1343.
42. Brennan A.L., Gyi K.M., Wood D.M., et al. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007, 6:101-109.
43. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345(19):1359-1367.
44. Ascione R., Rogers C.A., Rajakaruna C., Angelini G.D. Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 2008, 118:113-123.
45. Van den Berghe G., Schetz M., Vlasselaers D., et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. J Clin Endocrinol Metab 2009, 94:3163-3170.
46. Derde S., Vanhorebeek I., Van den Bergh G. Insulin treatment in intensive care patients. Horm Res 2009, 71:2-11.
47. Marshak S., Leibowitz G., Bertuzzi F., et al. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 1999, 48(6):1230-1236.
48. Ling Z., Pipeleers D.G. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 1996, 15:2805-2812.